Procurement Summary
Country : USA
Summary : 640-26-1-050-0003 | 36C261-25-AP-3235 | FY 26 LUTATHERA 16 doses | 36F79719D0169
Deadline : 10 Jun 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 120328324
Document Ref. No. : 36C26126Q0003
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Description
Special NoticeSpecial NoticePage 3 of 3*= Required FieldPage 1 of 3This notice is published IAW Federal Acquisition Regulation (FAR) Subpart 5.101 requiring posting of information for proposed contract actions. The Department of Veterans Affairs (VA), Network Contracting Office (NCO) 21 intends to award a sole source firm-fixed price contract to Novartis Pharmaceuticals Corporation under the authority of FAR 8.405-6(a)(1)(B), Only one source is capable of providing the supplies or services required at the level of quality required because the supplies or services are unique or highly specialized. The North American Industry Classification System (NAICS) for this requirement is 325412, Pharmaceutical Preparation Manufacturing. The Federal Supply Class (FSC) is 6505, Drugs and Biologicals. The Small Business Administration (SBA) size standard for this sector is 1, 300 Employees. VA Palo Alto Healthcare System Nuclear Medicine Department has a requirement for Lutathera (lutetium Lu 177 Dotatate), a radioactive therapy treatment for gastroenteropancreatic neuroendocrine tumors (GEP-NETs).If your firm provides the radiopharmaceutical therapy on GSA Federal Supply Schedule or any Federal Supply Schedule, please provide applicable contract number and identify which supply/service are applicable to that FSS contract, and the following additional information (1) A tailored capability statement indicating the firm s ability to provide a product and related services; (2) The respondents SAM UEI number, organization name, address, point of contact, and size and type of business (e.g., SDVOSB/VOSB, etc., ) pursuant to the applicable NAICS code; (3) Information should be provided electronically in a Microsoft Word or Adobe PDF format. Potential offerors must be a manufacturer or fully licensed, authorized distributor for the radiopharmaceutical items. Potential offerors must be FDA certified.This notice of intent is not a request for competitive quotes. However, int...
Active Contract Opportunity
Notice ID : 36C26126Q0003
Related Notice
Department/Ind. Agency : VETERANS AFFAIRS, DEPARTMENT OF
Sub-tier : VETERANS AFFAIRS, DEPARTMENT OF
Office: 261-NETWORK CONTRACT OFFICE 21 (36C261)
General Information
Contract Opportunity Type: Special Notice (Original)
Original Published Date: Jun 03, 2025 05:36 pm PDT
Original Response Date: Jun 10, 2025 03:00 pm PDT
Inactive Policy: Manual
Original Inactive Date: Aug 09, 2025
Initiative: None
Classification
Original Set Aside:
Product Service Code: 6505 - DRUGS AND BIOLOGICALS
NAICS Code: 325412 - Pharmaceutical Preparation Manufacturing
Place of Performance:
Documents
Tender Notice